NCCCP Biospecimens (BIOSPEC) Breakout Session Carolyn Compton, MD, PhD James Robb, MD Office of Biorepositories and Biospecimen Research (OBBR), NCI June.

Slides:



Advertisements
Similar presentations
Support.ebsco.com Nursing Reference Center Tutorial.
Advertisements

The Joint Commission Chapter update: Waived Testing
The IndianaCTSI Biorepository is committed to serving the repository needs for CTSI investigators. The core will tailor specimen management to the needs.
 Meeting the needs of cancer survivors across the lifespan Norton Cancer Institute Survivorship Program Christy Roberts, RN, BSN, OCN.
Population Management & Reporting. Federally-designated Regional Extension Center for the State of Missouri  University of Missouri:  Department of.
For Additional Agendas or Details about the TDAP Program Contact Barbara Kavanagh at AzMN © 2009 AzMN’s Tissue Donor Awareness.
ATA Practice Guidelines for Video- based Online Mental Health Services “The guidelines pertain to telemental health conducted between two parties, and.
Stacy A. Rudnicki, M.D. Brendan C. Stack, Jr., M.D., FACS, FACE.
Biospecimens Carolyn Compton, MD, PhD James Robb, MD Office of Biorepositories and Biospecimen Research (OBBR), NCI June 25, 2007.
EVALUATION OVERVIEW: Key Questions and Roles Mary L. Fennell, Ph.D. (EOC Chair) Professor and Chair, Brown University June 19, 2007.
What Happens after You Sign with Missouri Health Information Technology Assistance Center?
Nina Muscillo and Andrew Hargreaves November 2014 Supporting Medication Reconciliation.
Nursing Reference Center Plus Tutorial support.ebsco.com.
St. Joseph Hospital Cancer Center & Cancer Institute NCCCP Pilot Project.
The Molecular Diagnostics Research Laboratory University of Malaya Development and Implementation of a Quality System The Molecular Diagnostics Research.
Renee Otter WP5 leader. Health Strategies in Europe. Lisbon, July Coleman M.
Diagnostic Assays to Plan Specific Drug Treatment Elizabeth Hammond MD.
Nurse Staffing in New Hampshire Implementing a Nurse Staffing Committee NH Staffing Toolkit July 2010.
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Mary Beth Schell Adam Dodd NC AHEC Digital Library National AHEC: Wednesday June 23, 2010 Using Social Networking Tools to Support Graduate Medical Education:
In Shape From: National Registry of Evidence- based Programs and Practices (NREPP) Trey Thomas 11/19/2012 Health 313_01 Drugs and Human Behavior.
Research Day Sustainable TeleHealthcare delivery model for diverse socio-economic communities in New York City.
Biorepository Software Selection University of Michigan 31-Aug-2012 Frank Manion, Chief Information Officer Paul McGhee, Lead Business Analyst Cancer Center.
December 2006 MAGE and the Biospecimen Research Database Experiment Design and other issues Ian Fore, D.Phil U.S. National Cancer Institute - Center for.
PHYSICIAN ENGAGEMENT FORUM Arizona Critical Access Hospital Quality Network Arizona Rural Hospital Flexibility Program Roy Farrell, MD Chief Medical Officer.
CAP -State Pathology Society Leadership Conference June 29, 2007.
The National Biomedical Imaging Archive (NBIA) In Action: An Introduction for Users A Tool Demonstration from caBIG® Presented by: Eliot Siegel, MD Maryland.
Managing Advanced Illness to Advance Care Executive Briefing - AHA Annual Meeting Tuesday, April 30, :45am – 12:15pm © 2012 American Hospital Association.
Together.Today.Tomorrow. The BLUES Project Karen C. Fox, PhD Chief Executive Officer.
CRIX: toward a secure, standards-based, clinical research information exchange.
A Model for Translating Research into Practice in the United States - Mexico Border Region Howard J. Eng, MS, DrPH Director, Southwest Border Rural Health.
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Resources. Behavioral Health providers are being challenged to adopt health information technology with very limited resources. There is a need to prepare.
Resident Education in Molecular and Genomic Pathology Jeffrey E. Saffitz, MD, PhD Mallinckrodt Professor of Pathology Harvard Medical School Chair, Department.
BIOSPECIMENS: The Source of Biomarkers Carolyn Compton, MD, PhD National Biomarkers Development Alliance Public Forum Arizona State University March 25,
Scaling Patient Engagement Todd Rowland MD Experienced Professional Focused on Health Care Re-Design and Informatics
Extended Scope of Practice Projects Request For Proposal Information Session Friday 2 March 2012, 2.30pm pm Extended Scope of Practice – Extended.
New Jersey Academy of Family Physicians and Horizon Blue Cross Blue Shield of New Jersey Pilot Project July 28, 2010 © NJAFP Cari Miller, Director,
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Accountable Care Organizations: What is the role of the pathologist? What are the public policy implications?
PROMOTION AND TENURE FOR CLINICAL EDUCATORS Laura Lamps, M.D. Stacy Rudnicki, M.D.
Evaluation Plan Steven Clauser, PhD Chief, Outcomes Research Branch Applied Research Program Division of Cancer Control and Population Sciences NCCCP Launch.
NCCCP Biospecimens (BIOSPEC) Breakout Session Carolyn Compton, MD, PhD James Robb, MD Office of Biorepositories and Biospecimen Research (OBBR), NCI June.
PhUSE Computational Science Working Groups Solutions Through Collaboration.
ECIDC Regional Broadband Summit Illinois Rural HealthNet Update on Construction and New Funding Possibility December 6,
NCCCP Pilot – Clinical Trials Ann O’Mara, PhD, RN, FAAN Program Director Community Clinical Oncology Program Division of Cancer Prevention June 26, 2007.
NCI Community Cancer Centers Program (NCCCP) Kate Castro, RN, MS, AOCN ® Nurse Consultant National Cancer Institute, Outcomes Research Branch Kate Castro,
The National Cancer Imaging Archive (NCIA) In Action: An Introduction for Users A Tool Demonstration from caBIG™ Carl Jaffe, MD NCI-Cancer Imaging Program.
CQN Team Presentation Ohio Cleveland Clinic Children’s Hospital Kim Giuliano, MD Sharon O’Brien, MA Ivana Wilson, Medical Secretary.
Enterprise Customer/ Field Services Overview of Client Integration Processes August 9, 2012.
DOQ-IT Project The EHR Roadmap Tony Linares, MD Medical Director, Quality Improvement.
Electronic CAP Cancer Checklists and Cancer Registries – A Pilot Project 2009 NAACCR Conference Ken Gerlach, MPH, CTR Castine Verrill, MS, CTR CDC-National.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
NPCR – Advancing E-cancer Reporting and Registry Operations (NPCR-AERRO): An Update on Innovative Activities NAACCR Annual Conference June 16, 2009 Sandy.
Clinical Decision Support Implementation Victoria Ferguson, COO - Program Manager Christopher Taylor, CIO – Business Owner Monica Kaileh, CMIO – Steering.
National Association of Area Agency on Aging Conference July 2009.
SNOMED CT and Surgical Pathology
Tissue Collection & Banking Facility
Semantic Web - caBIG Abstract: 21st century biomedical research is driven by massive amounts of data: automated technologies generate hundreds of.
Patient Biospecimen Preanalytics:
Node Mentoring Redux.
(Public Sector Linkage Programme)
Lehigh Valley Health Network: Community Care Team Compact
Agenda What and why? Regional system components Path forward.
Golubev Alexandr, IMU Workshop, Chisinau 2018
SYNOPSIS OF THE PROTOCOL
Welcome to the University of Cincinnati’s Women in Medicine & Science Chapter! With Special Guest, Dr. Andrew Filak Jr. Interim Dean of the College.
UAB Tissue Biorepository
Presentation transcript:

NCCCP Biospecimens (BIOSPEC) Breakout Session Carolyn Compton, MD, PhD James Robb, MD Office of Biorepositories and Biospecimen Research (OBBR), NCI June 26, 2007

From Light Microscopy to Personalized Molecular Medicine: are you ready? Biospecimens agenda: James Robb, MD Brief biography Contact information sheet: 2 per hospital Monthly conference calls: 4 th Tuesday, 1-3 pm Eastern Paradigm shift to “molecular” pathology testing: AP & CP New “targeted molecular drugs”: Pathology has key role – Patient selection & proficiency testing: Her2 as example - CAP/ASCO – Pharmacogenomic testing for timing and dose of drugs – Toxicity testing – Efficacy testing Primary 3 year goal for Biospecimens portion of NCCCP: identify “gaps” Overview of Best Practices for Biospecimen Resources and pathology departmental checklists: make sure we all on the same page Other topics Next steps

Personalized Molecular Medicine or Molecular Abyss? It ‘s all in the biospecimen! Tidelands = “premolecular” testing: serum albumin, glucose (grams: 10 0 ) Shelf = Early molecular tests: fibrinogen/PSA + Light Micro (milli/micrograms: 10 -3/-6) ) Plateau = current molecular tests: Troponins/BNP (nano/picograms: 10 -9/-12 ) Abyssl plane = future tests: (attograms: ) 1. Approach the future via the Blake Ridge (step by step) with development and implementation of evidence-based, best practice biospecimen collecting, annotating, processing, storing, and privacy protocols OR 2. Expand rapidly into the abyss: excellent tests with inadequately annotated, collected, processed, stored, & private biospecimens

New Targeted Molecular Drugs: Herceptin/Her2 Slide #1 Test for eligible patients: Her2 Timing and dose of drug: pharmacogenomics Toxicity in eligible patients: “toxicogenomics” Efficacy of drug against disease: “efficogenomics”

New Targeted Molecular Drugs: Herceptin/Her2 Slide #2 Her2 (CAP/ASCO guidelines: handout) Formalin fixation: >6 hours, less than 48 hours – The required proficiency testing for breast cancers is the current “gold standard”. – This requirement for breast cancers requires significant review and modification of surgery/pathology/histology work flow patterns. – This light microscopy to molecular personalized medicine paradigm shift will become the standard for all malignant and non-malignant diagnostic tissue and cellular formalin-fixed biospecimens.

New Targeted Molecular Drugs: Herceptin/Her2 Slide #3 Molecular mechanism of formalin fixation Aqueous phase penetrates tissue rapidly Formaldehyde crosslinks proteins slowly – 6-48 hours for optimal ER IHC (used for Her2) Goldstein paper (handout) – AJCP 2003;120:86-92 formaldehyde  methylene glycol Must measure/estimate formalin fixation time and put into pathology report: transport + processing CAP creating pathology/laboratory reporting protocols similar to the cancer protocols.

Biospecimen Best Practice Protocols Office of Biorepositories and Biospecimen Research (OBBR) biospecimens.cancer.gov – Biospecimen Research Network (BRN): biospecimens.cancer.gov – Identify/create evidence-based current best practice protocols for every cancer-related analyte on every testing platform for every type of patient biospecimen: working with RAND corporation – Identify “gaps” in the evidence and do or contract the research necessary to fill in the gaps (intramural and extramural-worldwide) – All protocols to be vetted by the College of American Pathologists (CAP) Scientific Resource Committees: will be in public domain Similar process to current CAP Cancer Protocols – BRN website for published and unpublished data concerning collection, transporting, processing, and storing biospecimens Ideally be “ice cube tray”: information for every analyte for every testing platform for every type of biospecimen

Identify Biospecimen Best Practice “Gaps” at Each Hospital What are the “gaps” between the current state and full adoption of the Best Practices for Biospecimen Resources ? What will it take to fill in the identified “gaps”? – Workflow in pathology, surgery, nursing, etc. – Professional and technical staff requirements – Physical laboratory and/or biospecimen storage changes – Case reporting: CAP unified AP/CP reporting project Similar to CAP Cancer Protocols – IT changes to support caBIG connectivity or implementation What will it cost to fill in the identified “gaps”? Biospecimens and IT: will mentor a hospital for changes it wishes to implement - not a requirement of 3 year project

Review of BIOSPEC “Gap” Evaluation Matrix Slide #1 Review components of Matrix – Pathology departmental detail – Best Practices for Biospecimen Resources checklist Matrix will be completed with Evaluation Contractor – Complete within one year – As completed, use Matrix to place each hospital into one of four tiers Baseline: – Stand-Alone Pathology Laboratory Work Process – Site-specific Operating Procedures (SOPs) – No or Minimal Biospecimen Annotation

Review of BIOSPEC “Gap” Evaluation Matrix Slide #2 Tier 1: Baseline plus: – Identify collaboratively and deploy Best Practices for Biospecimen Resources (BPs) that would add value to the site, either » using NCICB as an application service provider (caBIG), or » installing infrastructure locally, or » adapting local systems to share data in a caBIG™ compliant manner Tier 2: Tier 1 plus: – Use local electronic medical record infrastructure, either pre-existing or open source, to prototype an end-to-end clinical research data pipeline for biospecimen annotation, collection, processing, reporting, and storing Tier 3: Tier 2 plus: – Primary pilot site sharing data bidirectionally with secondary site(s), or – Two or more pilot sites sharing data bidirectionally with common clinical data warehouse

Other Topics/Questions & Next Steps Other topics Questions Next steps – Complete Pathologist Contact Information List Two pathologists per : phone and address – Test BIOSPEC group (from above list) – 1 st Monthly Conference Call: 4 th Tuesday, 1-3 pm Eastern At least one pathologist or designee for each HOSPITAL – Additional attendees welcome July 24: 1-3 pm Eastern SAIC staff person will be present for helping with infrastructure/contract/etc. items and taking minutes